Circadian Intervention to Improve Cardiometabolic Health
Recruiting · NCT05943626 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Utah
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervention is designed to reduce nighttime light exposure and after-dinner snack food intake. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).
Who can take part
Inclusion criteria
- Age: 18-45 years old; equal numbers of men and women
- Body mass index (BMI): 25.0-34.9 kg/m2,
- Sleep Habits: habitual self-reported average total sleep time (TST) \<6.5 hours per night for prior 6 months
Exclusion criteria
- Clinically diagnosed sleep disorder or major psychiatric illness
- Evidence of significant organ dysfunction or disease (e.g., diagnosed diabetes, cardiovascular disease, or kidney disease)
- Use of prescription drugs or substances known to influence sleep or glucose metabolism
- Shift-work: current or history of within last year
- Weight change: \>10% of body weight over prior six months
- Experiencing menopause or post-menopausal
- Current enrollment in weight loss or physical activity program like the Diabetes Prevention Program
- Currently pregnant or planning to become pregnant, or currently lactating.
- Currently smoking
- Alcohol intake \>3 drinks per day or \>14 drinks per week
Where it is running
1 location listed across 1 US state.
- College of Health Research Complex--University of Utah - Salt Lake City, Utah, United States